About Salzman Group
Salzman Group is a company based in Beverly (United States) founded in 1996 by Andrew Salzman was acquired by Kalytera Therapeutics in May 2020.. Salzman Group operates in a competitive market with competitors including Escient Pharmaceuticals, Nimbus Therapeutics, Septerna, Upstream Bio and ACELYRIN, among others.
- Headquarter Beverly, United States
- Founders Andrew Salzman
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$492.8 K (USD), Grant
Apr 30, 2012
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Kalytera Therapeutics
(May 19, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Salzman Group
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $492,804
-
First Round
First Round
(15 Jan 2011)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2012 | Amount | Grant - Salzman Group | Valuation |
investors |
|
| Sep, 2011 | Amount | Grant - Salzman Group | Valuation |
investors |
|
| Apr, 2011 | Amount | Grant - Salzman Group | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Salzman Group
Salzman Group has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Kalytera Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Cannabinoid therapies for osteoporosis and bone healing are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Salzman Group
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Salzman Group
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Salzman Group Comparisons
Competitors of Salzman Group
Salzman Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Escient Pharmaceuticals, Nimbus Therapeutics, Septerna, Upstream Bio and ACELYRIN, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
GPCR drug discovery platform is developed for multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for allergic and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Immunological drug candidates are developed for severe diseases.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule-based therapies for treating immunological disorders, inflammation, and cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Salzman Group
Frequently Asked Questions about Salzman Group
When was Salzman Group founded?
Salzman Group was founded in 1996 and raised its 1st funding round 15 years after it was founded.
Where is Salzman Group located?
Salzman Group is headquartered in Beverly, United States. It is registered at Beverly, Massachusetts, United States.
Who is the current CEO of Salzman Group?
Andrew Salzman is the current CEO of Salzman Group. They have also founded this company.
What does Salzman Group do?
Salzman Group was founded in 1996 in Beverly, United States, within the biotechnology sector. Small molecule-based therapeutics for Crohns disease treatment are being advanced, with the lead candidate RvE1 derived from eicosapentaenoic acid and designed to bind the ChemR23 receptor on gut cells to reduce inflammation. This product is in Phase 1 clinical trials. Another candidate, R-107, is being developed for chlorine inhalation lung injury.
Who are the top competitors of Salzman Group?
Salzman Group's top competitors include Escient Pharmaceuticals, Nimbus Therapeutics and Alpine Immune Sciences.
Who are Salzman Group's investors?
Salzman Group has 2 investors. Key investors include HHS, and Kalytera Therapeutics.